Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03902587 · ClinicalTrials.gov registry record
Application of Cervical Elastography in Obstetrics
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT03902587 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 1,000 participants.
The verdict
NCT03902587 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth. During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.
Interventions
- DEVICE Samsung's E-cervix technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2021-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03902587
The ClinicalTrials.gov registry entry for NCT03902587 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Samsung's E-cervix technology is the first listed.
NCT03902587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03902587 about?
NCT03902587 is a clinical study titled "Application of Cervical Elastography in Obstetrics". The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth. During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cerv...
What is the current status of trial NCT03902587?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2019-03-04. Estimated completion is 2021-01-25.
What interventions are being tested in trial NCT03902587?
The interventions under investigation include: Samsung's E-cervix technology (DEVICE).
Who is sponsoring clinical trial NCT03902587?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.